Blogs

The Power of Precision: How J&J is Working to Deliver the Promise of Precision Medicine to Patients with Complex Disease

April 25, 2024
Gabriele Alegri
Data Science

Cracking the Code: How New Clues in Our Blood Could Sharpen Our Understanding of Diseases and Impact How We Treat Them

October 4, 2023
Chris Whelan
Oncology newsroom

Progress in the Journey to Transform the Treatment of Bladder Cancer

April 30, 2023
Christopher Cutie, M.D.
Blogs

One Size Fits Not: The “E’s” of Accessible Transformational Medicines for Those Living with Rare Diseases

February 28, 2023
Christoph Glaetzer, Dipl. KFM.
Oncology newsroom

Building Equitable Access For Patients With Lung Cancer

Building equitable access to next-generation sequencing and targeted therapies for all patients with lung cancer

November 1, 2022
Joshua Bauml, M.D.
Blogs

Here’s How We Can: Co-Creating Solutions as Regulatory Professionals

Here’s how we can: Co-creating solutions as regulatory professionals.

June 21, 2022
Karin Van Baelen, PharmD
Clinical Trials: Against All Odds

A Janssen leader’s reflections on ‘Clinical Trials: Against All Odds’

May 17, 2022
Peter Ronco

Newsroom

Visit our newsroom to see latest press releases from Johnson & Johnson Innovative Medicine.

March 19, 2024

Learn more